Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1974 1
1975 2
1976 2
1978 2
1979 4
1980 4
1981 4
1982 2
1983 1
1984 5
1985 6
1986 2
1987 5
1988 2
1989 2
1990 1
1991 2
1993 8
1994 4
1995 1
1997 1
1998 6
2001 2
2003 4
2008 2
2011 5
2012 4
2013 2
2014 3
2015 4
2016 5
2017 1
2018 2
2019 2
2020 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
International consensus guidance for management of myasthenia gravis: Executive summary.
Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P. Sanders DB, et al. Among authors: richman dp. Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29. Neurology. 2016. PMID: 27358333 Free PMC article. Review.
Reply.
Sanders DB, Harati Y, Juel VC, Lou JS, Marburger T, Pascuzzi RM, Peltier AC, Richman DP, Smith AG. Sanders DB, et al. Among authors: richman dp. Muscle Nerve. 2018 May;57(5):E130-E131. doi: 10.1002/mus.26089. Epub 2018 Mar 1. Muscle Nerve. 2018. PMID: 29406616 No abstract available.
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.
Oh S, Mao X, Manfredo-Vieira S, Lee J, Patel D, Choi EJ, Alvarado A, Cottman-Thomas E, Maseda D, Tsao PY, Ellebrecht CT, Khella SL, Richman DP, O'Connor KC, Herzberg U, Binder GK, Milone MC, Basu S, Payne AS. Oh S, et al. Among authors: richman dp. Nat Biotechnol. 2023 Sep;41(9):1229-1238. doi: 10.1038/s41587-022-01637-z. Epub 2023 Jan 19. Nat Biotechnol. 2023. PMID: 36658341 Free PMC article.
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team. Nowak RJ, et al. Among authors: richman dp. Neurology. 2022 Jan 25;98(4):e376-e389. doi: 10.1212/WNL.0000000000013121. Neurology. 2022. PMID: 34857535 Free PMC article.
Muscle-Specific Kinase Myasthenia Gravis.
Borges LS, Richman DP. Borges LS, et al. Among authors: richman dp. Front Immunol. 2020 May 8;11:707. doi: 10.3389/fimmu.2020.00707. eCollection 2020. Front Immunol. 2020. PMID: 32457737 Free PMC article. Review.
The Future of Research in Myasthenia.
Richman DP. Richman DP. JAMA Neurol. 2015 Jul;72(7):812-4. doi: 10.1001/jamaneurol.2014.4740. JAMA Neurol. 2015. PMID: 26011044 Review. No abstract available.
Thymectomy and myasthenia gravis.
Lisak RP, Richman DP. Lisak RP, et al. Among authors: richman dp. Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32195-32196. doi: 10.1073/pnas.2022901117. Epub 2020 Dec 3. Proc Natl Acad Sci U S A. 2020. PMID: 33273117 Free PMC article. No abstract available.
Treatment of autoimmune myasthenia gravis.
Richman DP, Agius MA. Richman DP, et al. Neurology. 2003 Dec 23;61(12):1652-61. doi: 10.1212/01.wnl.0000098887.24618.a0. Neurology. 2003. PMID: 14694025 Review.
106 results